EGFR mutation trang 1 tải miễn phí từ TAILIEUCHUNG

"EGFR mutation" trang 1 - tải miễn phí từ Tailieuchung

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

10 31 1

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer

8 43 1

Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients

Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients

8 48 1

Study on rate and some risk factors for egfr mutation in 152 patients with lung adenocarcinoma at Bachmai hospital

Study on rate and some risk factors for egfr mutation in 152 patients with lung adenocarcinoma at Bachmai hospital

5 64 0

Targeting TKI resistance in non - small cell lung cancer patients caused by secondary EGFR T790m mutation

Targeting TKI resistance in non - small cell lung cancer patients caused by secondary EGFR T790m mutation

9 68 0

Potential genetic modifiers for somatic EGFR mutation in lung cancer: A metaanalysis and literature review

Potential genetic modifiers for somatic EGFR mutation in lung cancer: A metaanalysis and literature review

17 159 0

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

13 43 0

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

5 38 1

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

7 28 1

Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis

Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis

11 44 1

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

4 35 1

Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: A case report

Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: A case report

5 32 1

A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027

A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027

10 17 1

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

11 11 1

Detection of EGFR mutation and its association with clinicopathological features of non-small cell lung cancer patients

Detection of EGFR mutation and its association with clinicopathological features of non-small cell lung cancer patients

5 6 1

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

4 51 0

Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: A comparative study

Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: A comparative study

8 37 1

AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations

AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations

8 59 1

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

9 32 1

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

9 38 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.